MMP2 and lung carcinoma: MMP-2 upregulation has been detected in melanoma [32], breast [33,34], ovarian [35,36], pancreatic [37,38], prostate [39,40], and lung cancers [31,41], among others, and associates with metastasis or poor prognosis.